NPI: 1801158498 · LAGUNA HILLS, CA 92653 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 06/11/2012
Authorized official WEY, SAM controls 14+ related entities in our dataset. Read more
| Authorized Official | WEY, SAM (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 06/11/2012 |
Other providers sharing the same authorized official: WEY, SAM
| Provider | City | State | Total Paid |
|---|---|---|---|
| SAPELO DIALYSIS LLC | SAN LEANDRO | CA | $9.71M |
| DVA HEALTHCARE RENAL CARE INC | CHINO | CA | $4.52M |
| TRAILSTONE DIALYSIS LLC | ONTARIO | CA | $2.63M |
| DVA HEALTHCARE RENAL CARE INC | SAN FRANCISCO | CA | $1.82M |
| CAPES DIALYSIS LLC | SEARCY | AR | $1.51M |
| TOTAL RENAL CARE INC | SANTA ROSA | CA | $818K |
| RENAL TREATMENT CENTERS-SOUTHEAST, LP. | GRETNA | LA | $796K |
| TARGHEE DIALYSIS, LLC | CINCINNATI | OH | $514K |
| GREENWOOD DIALYSIS LLC | TULSA | OK | $74K |
| DVA RENAL HEALTHCARE INC | DURHAM | NC | $10K |
| RENAL CENTER OF MOOREFIELD LLC | MOOREFIELD | WV | $8K |
| BLISS DIALYSIS LLC | BROKEN ARROW | OK | $6K |
| SAKDC - DAVITA DIALYSIS PARTNERS LP | FLORESVILLE | TX | $0.00 |
| VILLAGEHEALTH DM LLC | DENVER | CO | $0.00 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 6,198 | $269K |
| 2019 | 9,253 | $346K |
| 2020 | 12,821 | $355K |
| 2021 | 11,176 | $325K |
| 2022 | 3,830 | $278K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,424 | 1,264 | $1.18M |
| A4657 | Syringe, with or without needle, each | 662 | 559 | $297K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,668 | 486 | $59K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 13,672 | 789 | $15K |
| J1756 | Injection, iron sucrose, 1 mg | 2,860 | 700 | $15K |
| 82728 | 210 | 172 | $5K | |
| 83540 | 278 | 215 | $2K | |
| 85041 | 648 | 516 | $406.30 | |
| 82108 | 13 | 13 | $226.27 | |
| 83970 | 212 | 172 | $36.60 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 48 | 27 | $29.85 |
| G0008 | Administration of influenza virus vaccine | 12 | 12 | $19.53 |
| 83550 | 278 | 215 | $7.54 | |
| 85048 | 622 | 499 | $7.19 | |
| 85045 | 67 | 48 | $3.07 | |
| 0634 | 321 | 15 | $0.00 | |
| 0636 | 191 | 13 | $0.00 | |
| 0301 | 55 | 12 | $0.00 | |
| 0305 | 37 | 12 | $0.00 |